Business

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - StockStory

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.3% year on year ...

U2Fx.comU2Fx.com
Aug 7, 2026 - 12:00
 0  15
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - StockStory
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.3% year on year ...
Read More

Tags:

Previous Article

Rail passengers facing more disruption after power outage; UK house prices stagn...

Next Article

MGA consolidation reaches trucking insurtech HDVI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

People in Business: FOCUS names; Nitrous Effect appoints; EDC names; West Community promotes

People in Business: FOCUS names; Nitrous Effect appoint...

U2Fx.com Aug 16, 2026  0  20

Columbus Partnership CEO out after creating 'bullying' culture, insiders say

Columbus Partnership CEO out after creating 'bullying' ...

U2Fx.com Jun 23, 2026  0  13

Eaton to Merge Mobility Business With Dana in $10B Deal

Eaton to Merge Mobility Business With Dana in $10B Deal

U2Fx.com Jun 11, 2026  0  16